Surrey Heartlands

Joint Formulary & PAD

Celecoxib - Pain & inflammation - musculoskeletal

You are here : Home > Formulary Search > Celecoxib - Pain & inflammation - musculoskeletal

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Preferred

Documentation

Safety Information
NSAIDs - Safer Prescribing Aide Memoir - Jul 2019
Evidence Review
COX-II colour change classification paper Jul-19.docx

PAD Profile

ChemicalSubstance :
Celecoxib
Indication :
Pain & inflammation - musculoskeletal
Group Name :
Keywords :
COXIIs, Coxib, cyclo-oxygenase-2, osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, PNMP
Brand Names Include :
Celebrex
Important Information :
Preferred COX II inhibitor for licensed indications
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Celecoxib is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Pain & inflammation - musculoskeletal.

Committee Recommendations (1)

03 Jul 19 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey & North West Sussex Area Prescribing Committee recommends celecoxib as a treatment option for the treatment of pain and inflammation in line with the product licence*.

Celecoxib will be considered as GREEN on the traffic light system and is the preferred COX II inhibitor for use where a COX II inhibitor is indicated.

*Licenced for: Osteoarthritis, Rheumatoid Arthritis & Ankylosing Spondylitis

The branded product, Celebrex, is considered BLACK. Prescribe generically for this indication.